Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer.

Rice MA, Malhotra SV, Stoyanova T.

Front Oncol. 2019 Aug 28;9:801. doi: 10.3389/fonc.2019.00801. eCollection 2019. Review.

2.

Dimethylsphingosine and miltefosine induce apoptosis in lung adenocarcinoma A549 cells in a synergistic manner.

Uzunova V, Tzoneva R, Stoyanova T, Pankov R, Skrobanska R, Georgiev G, Maslenkova L, Tsonchev Z, Momchilova A.

Chem Biol Interact. 2019 Sep 1;310:108731. doi: 10.1016/j.cbi.2019.108731. Epub 2019 Jun 29.

PMID:
31265827
3.

Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies.

Rice MA, Hsu EC, Aslan M, Ghoochani A, Su A, Stoyanova T.

Mol Cancer Ther. 2019 Jul;18(7):1230-1242. doi: 10.1158/1535-7163.MCT-18-0804. Epub 2019 Apr 26.

PMID:
31028097
4.

Study of potential biomedical application of sol-gel derived Zn-doped SiO2-hydroxypropyl cellulose nanohybrids.

Angelova T, Rangelova N, Georgieva N, Nemska V, Stoyanova T, Uzunova V, Aleksandrov L, Tzoneva R.

Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:608-615. doi: 10.1016/j.msec.2019.03.018. Epub 2019 Mar 6.

PMID:
30948097
5.

Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer.

Going CC, Tailor D, Kumar V, Birk AM, Pandrala M, Rice MA, Stoyanova T, Malhotra S, Pitteri SJ.

J Proteome Res. 2018 Oct 5;17(10):3574-3585. doi: 10.1021/acs.jproteome.8b00636. Epub 2018 Sep 20.

PMID:
30200768
6.

New cycloartane triterpenes from bioactive extract of propolis from Pitcairn Island.

Georgieva K, Trusheva B, Uzunova V, Stoyanova T, Valcheva V, Popova M, Tzoneva R, Bankova V.

Fitoterapia. 2018 Jul;128:233-241. doi: 10.1016/j.fitote.2018.05.024. Epub 2018 May 23.

PMID:
29800610
7.

Xanthates: Metabolism by Flavoprotein-Containing Monooxygenases and Antimycobacterial Activity.

Yanev SG, Stoyanova TD, Valcheva VV, Ortiz de Montellano PR.

Drug Metab Dispos. 2018 Aug;46(8):1091-1095. doi: 10.1124/dmd.118.081984. Epub 2018 May 18.

8.

The Exosome Total Isolation Chip.

Liu F, Vermesh O, Mani V, Ge TJ, Madsen SJ, Sabour A, Hsu EC, Gowrishankar G, Kanada M, Jokerst JV, Sierra RG, Chang E, Lau K, Sridhar K, Bermudez A, Pitteri SJ, Stoyanova T, Sinclair R, Nair VS, Gambhir SS, Demirci U.

ACS Nano. 2017 Nov 28;11(11):10712-10723. doi: 10.1021/acsnano.7b04878. Epub 2017 Nov 1.

9.

Xanthates As Useful Probes for Testing the Active Sites of Cytochromes P450 4A11 and 2E1.

Stoyanova T, Lessigiarska I, Mikov M, Pajeva I, Yanev S.

Front Pharmacol. 2017 Sep 22;8:672. doi: 10.3389/fphar.2017.00672. eCollection 2017.

10.

Retraction for Roy et al., "DDB2, an Essential Mediator of Premature Senescence".

Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P.

Mol Cell Biol. 2017 May 16;37(11). pii: e00135-17. doi: 10.1128/MCB.00135-17. Print 2017 Jun 1. No abstract available.

11.

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.

Liu X, Grogan TR, Hieronymus H, Hashimoto T, Mottahedeh J, Cheng D, Zhang L, Huang K, Stoyanova T, Park JW, Shkhyan RO, Nowroozizadeh B, Rettig MB, Sawyers CL, Elashoff D, Horvath S, Huang J, Witte ON, Goldstein AS.

Cell Rep. 2016 Dec 6;17(10):2596-2606. doi: 10.1016/j.celrep.2016.11.010.

12.

v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.

Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Andò S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG.

Cancer Res. 2016 Nov 15;76(22):6723-6734. doi: 10.1158/0008-5472.CAN-15-3327. Epub 2016 Sep 15.

13.

Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.

Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6457-E6466. Epub 2016 Sep 30.

14.

Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.

Drake JM, Paull EO, Graham NA, Lee JK, Smith BA, Titz B, Stoyanova T, Faltermeier CM, Uzunangelov V, Carlin DE, Fleming DT, Wong CK, Newton Y, Sudha S, Vashisht AA, Huang J, Wohlschlegel JA, Graeber TG, Witte ON, Stuart JM.

Cell. 2016 Aug 11;166(4):1041-1054. doi: 10.1016/j.cell.2016.07.007. Epub 2016 Aug 4.

15.

Integrated Toolset for WSN Application Planning, Development, Commissioning and Maintenance: The WSN-DPCM ARTEMIS-JU Project.

Antonopoulos C, Asimogloy K, Chiti S, D'Onofrio L, Gianfranceschi S, He D, Iodice A, Koubias S, Koulamas C, Lavagno L, Lazarescu MT, Mujica G, Papadopoulos G, Portilla J, Redondo L, Riccio D, Riesgo T, Rodriguez D, Ruello G, Samoladas V, Stoyanova T, Touliatos G, Valvo A, Vlahoy G.

Sensors (Basel). 2016 Jun 2;16(6). pii: E804. doi: 10.3390/s16060804.

16.

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.

Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, Cheng D, Stuart JM, Shokat KM, Gustafson WC, Huang J, Witte ON.

Cancer Cell. 2016 Apr 11;29(4):536-547. doi: 10.1016/j.ccell.2016.03.001. Epub 2016 Mar 31.

17.

Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.

Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR.

Prostate. 2016 Feb;76(2):125-39. doi: 10.1002/pros.23107. Epub 2015 Oct 19. Review.

18.
19.

Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.

Stoyanova T, Cooper AR, Drake JM, Liu X, Armstrong AJ, Pienta KJ, Zhang H, Kohn DB, Huang J, Witte ON, Goldstein AS.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20111-6. doi: 10.1073/pnas.1320565110. Epub 2013 Nov 26.

20.

Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.

Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CM, Sud S, Titz B, Huang J, Pienta KJ, Graeber TG, Witte ON.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4762-9. doi: 10.1073/pnas.1319948110. Epub 2013 Nov 18.

21.

Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells.

Stoyanova TI, Goldstein AS.

Asian J Androl. 2013 Jan;15(1):83-4. doi: 10.1038/aja.2012.133. Epub 2012 Dec 3. No abstract available.

22.

Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling.

Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON.

Genes Dev. 2012 Oct 15;26(20):2271-85. doi: 10.1101/gad.196451.112.

23.

Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.

Cai H, Memarzadeh S, Stoyanova T, Beharry Z, Kraft AS, Witte ON.

Cancer Res. 2012 Sep 15;72(18):4672-81. Epub 2012 Jul 17.

24.

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.

Drake JM, Graham NA, Stoyanova T, Sedghi A, Goldstein AS, Cai H, Smith DA, Zhang H, Komisopoulou E, Huang J, Graeber TG, Witte ON.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1643-8. doi: 10.1073/pnas.1120985109. Epub 2012 Jan 17.

25.

p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies.

Stoyanova T, Roy N, Bhattacharjee S, Kopanja D, Valli T, Bagchi S, Raychaudhuri P.

J Biol Chem. 2012 Jan 27;287(5):3019-28. doi: 10.1074/jbc.M111.295816. Epub 2011 Dec 13.

26.

Cul4A is essential for spermatogenesis and male fertility.

Kopanja D, Roy N, Stoyanova T, Hess RA, Bagchi S, Raychaudhuri P.

Dev Biol. 2011 Apr 15;352(2):278-87. doi: 10.1016/j.ydbio.2011.01.028. Epub 2011 Feb 1.

27.

Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.

Goldstein AS, Stoyanova T, Witte ON.

Mol Oncol. 2010 Oct;4(5):385-96. doi: 10.1016/j.molonc.2010.06.009. Epub 2010 Jul 14. Review.

28.

DDB2, an essential mediator of premature senescence.

Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P.

Mol Cell Biol. 2010 Jun;30(11):2681-92. doi: 10.1128/MCB.01480-09. Epub 2010 Mar 29. Retraction in: Mol Cell Biol. 2017 May 16;37(11):.

29.

Recently revised diagnostic reference levels in nuclear medicine in Bulgaria and in Finland.

Korpela H, Bly R, Vassileva J, Ingilizova K, Stoyanova T, Kostadinova I, Slavchev A.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):317-20. doi: 10.1093/rpd/ncq009. Epub 2010 Feb 8.

PMID:
20142277
30.

DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response.

Stoyanova T, Roy N, Kopanja D, Raychaudhuri P, Bagchi S.

Cell Cycle. 2009 Dec 15;8(24):4067-71. Epub 2009 Dec 17. Review.

31.

DDB2 decides cell fate following DNA damage.

Stoyanova T, Roy N, Kopanja D, Bagchi S, Raychaudhuri P.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10690-5. doi: 10.1073/pnas.0812254106. Epub 2009 Jun 16.

32.

Proliferation defects and genome instability in cells lacking Cul4A.

Kopanja D, Stoyanova T, Okur MN, Huang E, Bagchi S, Raychaudhuri P.

Oncogene. 2009 Jul 2;28(26):2456-65. doi: 10.1038/onc.2009.86. Epub 2009 May 11.

33.

The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1.

Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P.

Mol Cell Biol. 2008 Jan;28(1):177-87. Epub 2007 Oct 29.

Supplemental Content

Loading ...
Support Center